Document Detail


Position of indapamide, a diuretic with vasorelaxant activities, in antihypertensive therapy.
MedLine Citation:
PMID:  22725706     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Diuretics play a pivotal role in the management of hypertension. A large experience has been accumulated with indapamide , a long-acting thiazide-like diuretic that lowers blood pressure (BP) primarily through its natriuretic diuretic effect. Some of its long-term antihypertensive efficacy may be due to calcium antagonist-like vasorelaxant activities. Indapamide has protecting effects in a variety of conditions associated with high cardiovascular risk, such as diabetes, left ventricular hypertrophy, nephropathy and stroke. It is highly effective in lowering BP, whether given alone or in combination. Indapamide is well tolerated and has the advantage of having no adverse impact on glucose and lipid metabolism. Today, thiazide-like diuretics are regarded more and more as preferred drugs, when diuretic therapy is required to lower BP.
AREAS COVERED: The aim of this paper is to review the experience accumulated with indapamide. It is limited to clinical studies that are relevant for the everyday management of hypertensive patients, whether or not they exhibit cardiovascular or renal disease.
EXPERT OPINION: Indapamide, because of its well-documented beneficial effects on cardiovascular and renal outcomes, represents a safe and valuable option for treating patients with high BP. There is, however, still room for new trials evaluating the combination of this diuretic with other types of antihypertensive drugs, in particular a calcium antagonist such as amlodipine. There is also the need to compare the indapamide-perindopril and indapamide-amlodipine combinations, in terms of antihypertensive efficacy, tolerability and effects on target organ damage and, ideally, on cardiovascular mortality.
Authors:
Bernard Waeber; Corina Rotaru; François Feihl
Related Documents :
22463426 - Interfacial alloy hydride destabilization in mg/pd thin films.
1981076 - Selective alpha 1 inhibition with doxazosin in hypertensive smokers and non-smokers: ha...
1535656 - Diurnal blood pressure and blood pressure variability in diabetic normotensive and hype...
10526906 - Fasting insulin and leptin serum levels are associated with systolic blood pressure ind...
9278706 - Sodium cyanate: from a promising therapeutic agent to a research tool in high altitude ...
3813076 - Cardiovascular effects of and interaction between calcium blocking drugs and anesthetic...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Expert opinion on pharmacotherapy     Volume:  13     ISSN:  1744-7666     ISO Abbreviation:  Expert Opin Pharmacother     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-06-25     Completed Date:  2012-11-20     Revised Date:  2013-11-06    
Medline Journal Info:
Nlm Unique ID:  100897346     Medline TA:  Expert Opin Pharmacother     Country:  England    
Other Details:
Languages:  eng     Pagination:  1515-26     Citation Subset:  IM    
Affiliation:
Centre Hospitalier Universitaire Vaudois and University of Lausanne, Division of Clinical Pathophysiology, Lausanne, Switzerland. Bernard.Waeber@chuv.ch
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antihypertensive Agents / therapeutic use*
Diuretics / therapeutic use
Humans
Hypertension / drug therapy*,  metabolism
Indapamide / therapeutic use*
Vasodilator Agents / therapeutic use
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Diuretics; 0/Vasodilator Agents; 26807-65-8/Indapamide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Chronic PDE-5 inhibition in patients with erectile dysfunction - a treatment approach using tadalaf...
Next Document:  Pregabalin for the treatment of fibromyalgia.